Thorsten Berger

9.3k total citations · 3 hit papers
48 papers, 6.0k citations indexed

About

Thorsten Berger is a scholar working on Molecular Biology, Nephrology and Immunology. According to data from OpenAlex, Thorsten Berger has authored 48 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Nephrology and 10 papers in Immunology. Recurrent topics in Thorsten Berger's work include Acute Kidney Injury Research (11 papers), Liver Disease and Transplantation (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Thorsten Berger is often cited by papers focused on Acute Kidney Injury Research (11 papers), Liver Disease and Transplantation (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Thorsten Berger collaborates with scholars based in Canada, United States and Germany. Thorsten Berger's co-authors include David R. McIlwain, TW Mak, Tak W. Mak, Andrew Wakeham, Andrew Elia, Gordon S. Duncan, Shawn P. Kubli, Carol C. Cheung, Daniel Vilarim Araújo and Lillian L. Siu and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Thorsten Berger

48 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Caspase Functions in Cell Death and Disease

2013 2.1k citations David R. McIlwain, Thorsten Berger et al. Cold Spring Harbor Perspectives in Biology profile →
Lipocalin-2 Resistance Confers an Advantage to Salmonella enterica Serotype Typhimurium for Growth and Survival in the Inflamed Intestine

2009 419 citations Thorsten Berger, Tak W. Mak et al. profile →
Beyond immune checkpoint blockade: emerging immunological strategies

2021 326 citations Shawn P. Kubli, Thorsten Berger et al. profile →

Peers

Countries citing papers authored by Thorsten Berger

Since Specialization

Citations

This map shows the geographic impact of Thorsten Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Berger more than expected).

Fields of papers citing papers by Thorsten Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thorsten Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Berger. The network helps show where Thorsten Berger may publish in the future.

Co-authorship network of co-authors of Thorsten Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Thorsten Berger. A scholar is included among the top collaborators of Thorsten Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thorsten Berger. Thorsten Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	B cell–derived acetylcholine mitigates skin inflammation in mice through α9 nicotinic acetylcholine receptor–mediated signaling 2025 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), (unknown), Jillian Haight, (unknown), Annick You-Ten, (unknown), (unknown), Andrew Elia, Thorsten Berger, Eleonora Candi, Gerry Melino, Tak W. Mak	2
2	Off-the-Shelf GMP-Compliant iPS Cells for Application in Cell Therapy 2025 ·Cytotherapy ·(unknown), (unknown), (unknown), (unknown), (unknown), Thorsten Berger, (unknown), (unknown), (unknown), Boris Greber	1
3	Choline acetyltransferase–expressing T cells are required to control chronic viral infection 2019 ·Science ·Maureen A. Cox, Gordon S. Duncan, Gloria Lin, Benjamin E. Steinberg, Lisa Yu, Dirk Brenner, (unknown), Andrew Elia, Andrew Wakeham, Brian J. Nieman, Carmen Dominguez‐Brauer, Alisha R. Elford, (unknown), Shawn P. Kubli, Jillian Haight, Thorsten Berger, Pamela S. Ohashi, Kevin J. Tracey, Peder S. Olofsson, Tak W. Mak	105
4	Lipocalin-2 induces NLRP3 inflammasome activation via HMGB1 induced TLR4 signaling in heart tissue of mice under pressure overload challenge. 2017 ·Queensland's institutional digital repository (The University of Queensland) ·Erfei Song, James W.S. Jahng, (unknown), Hye Kyoung Sung, Meng Han, (unknown), Donghai Wu, Stellar Boo, Boris Hinz, Matthew A. Cooper, Avril A. B. Robertson, Thorsten Berger, Tak W. Mak, Isaac George, P. Christian Schulze, Yu Wang, Aimin Xu, Gary Sweeney	45
5	Lipocalin‐2 (NGAL) Attenuates Autophagy to Exacerbate Cardiac Apoptosis Induced by Myocardial Ischemia 2017 ·Journal of Cellular Physiology ·Hye Kyoung Sung, Yee Kwan Chan, Meng Han, James W.S. Jahng, Erfei Song, Eric Danielson, Thorsten Berger, Tak W. Mak, Gary Sweeney	52
6	Lipocalin-2 in Fructose-Induced Fatty Liver Disease 2017 ·Frontiers in Physiology ·Jessica Lambertz, Thorsten Berger, Tak W. Mak, Josef van Helden, Ralf Weiskirchen	17
7	Beyond the Oncogene Revolution: Four New Ways to Combat Cancer 2016 ·Cold Spring Harbor Symposia on Quantitative Biology ·Thorsten Berger, Mary Saunders, Tak W. Mak	6
8	Absence of Intestinal PPARγ Aggravates Acute Infectious Colitis in Mice through a Lipocalin-2–Dependent Pathway 2014 ·PLoS Pathogens ·Parag Kundu, (unknown), Agata Korecka, Yinghui Li, Rossana D’Arienzo, Ralph M. Bunte, Thorsten Berger, Velmurugesan Arulampalam, Pierre Chambon, Tak W. Mak, Walter Wahli, Sven Pettersson	36
9	Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis 2013 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Erawan Borkham‐Kamphorst, Eddy Van de Leur, Henning W. Zimmermann, Karlin Raja Karlmark, Lidia Tihaa, Ute Haas, Frank Tacke, Thorsten Berger, Tak W. Mak, Ralf Weiskirchen	114
10	Dissection of Signaling in Inflammation: Three Novel Inflammatory Regulators 2013 ·Cold Spring Harbor Symposia on Quantitative Biology ·Thorsten Berger, (unknown), TW Mak	8
11	Caspase Functions in Cell Death and Disease breakdown → 2013 ·Cold Spring Harbor Perspectives in Biology ·David R. McIlwain, Thorsten Berger, TW Mak	2070
12	iRhom2 Regulation of TACE Controls TNF-Mediated Protection Against Listeria and Responses to LPS 2012 ·Science ·David R. McIlwain, Philipp A. Lang, Thorsten Maretzky, Koichi Hamada, Kazuhito Ohishi, Sathish Kumar Maney, Thorsten Berger, Aditya Murthy, Gordon S. Duncan, Haifeng C. Xu, Karl S. Lang, Dieter Häussinger, Andrew Wakeham, Annick Itie-YouTen, Rama Khokha, Pamela S. Ohashi, Carl Blobel, Tak W. Mak	259
13	Flotillin-2 deficiency leads to reduced lung metastases in a mouse breast cancer model 2012 ·Oncogene ·Thorsten Berger, Tsutomu Ueda, Enrico Arpaia, Iok In Christine Chio, Elize A. Shirdel, Igor Jurišica, Kazuya Hamada, Annick You-Ten, Jillian Haight, Andrew Wakeham, Carol C. Cheung, Tak W. Mak	49
14	Lipocalin 2 Regulates Inflammation during Pulmonary Mycobacterial Infections 2012 ·PLoS ONE ·Lokesh Guglani, Radha Gopal, Javier Rangel‐Moreno, (unknown), Yinyao Lin, Thorsten Berger, Tak W. Mak, John F. Alcorn, Troy D. Randall, Todd A. Reinhart, Yvonne R. Chan, Shabaana A. Khader	52
15	Lipocalin 2 performs contrasting, location-dependent roles in APCmin tumor initiation and progression 2012 ·Oncogene ·Patrick T. Reilly, (unknown), (unknown), (unknown), Carmen Dominguez‐Brauer, Andrew Elia, Thorsten Berger, Gediminas Greicius, Sven Pettersson, Tak W. Mak	18
16	Lipocalin 2 is essential for chronic kidney disease progression in mice and humans 2010 ·Journal of Clinical Investigation ·Amandine Viau, Khalil El Karoui, Denise Laouari, Martine Burtin, Clément Nguyen, Kiyoshi Mori, Évangéline Pillebout, Thorsten Berger, Tak W. Mak, Bertrand Knebelmann, Gérard Friedlander, Jonathan Barasch, Fabiola Terzi	302
17	Lipocalin 2 Is Required for Pulmonary Host Defense against Klebsiella Infection 2009 ·The Journal of Immunology ·Yvonne R. Chan, (unknown), Derek Pociask, Mingquan Zheng, Timothy A. Mietzner, Thorsten Berger, Tak W. Mak, Matthew C. Clifton, Roland K. Strong, Prabir Ray, Jay K. Kolls	182
18	Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury 2006 ·Proceedings of the National Academy of Sciences ·Thorsten Berger, Atsushi Togawa, Gordon S. Duncan, Andrew Elia, Annick You-Ten, Andrew Wakeham, (unknown), Carol C. Cheung, Tak W. Mak	380
19	Roles of SLC/CCL21 and CCR7 in Human Kidney for Mesangial Proliferation, Migration, Apoptosis, and Tissue Homeostasis 2002 ·The Journal of Immunology ·Bernhard Banas, Markus Wörnle, Thorsten Berger, Peter J. Nelson, Clemens D. Cohen, Matthias Kretzler, Jochen Pfirstinger, Matthias Mack, Martin Lipp, Hermann‐Josef Gröne, Detlef Schlöndorff	86
20	TRAIL-induced apoptosis is independent of the mitochondrial apoptosis mediator DAP3 2002 ·Biochemical and Biophysical Research Communications ·Thorsten Berger, Matthias Kretzler	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact